Francesca Del Sorbo
Overview
Explore the profile of Francesca Del Sorbo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazzetti S, Contaldi E, Basellini M, Novello C, Calogero A, Straniero L, et al.
Brain Pathol
. 2024 Sep;
34(6):e13284.
PMID: 39219308
The main genetic risk factors for Parkinson's disease (PD) are presently represented by variants in GBA1 gene encoding for the β-glucocerebrosidase (GCase). Searching for a peripheral biomarker that can be...
2.
Caronni S, Del Sorbo F, Barichella M, Fothergill-Misbah N, Denne T, Laguna J, et al.
Parkinsonism Relat Disord
. 2024 May;
124:106983.
PMID: 38797572
Parkinson's disease (PD) is a progressive and disabling neurodegenerative disease that rapidly worsens and results in premature mortality if left untreated. Although levodopa is the gold standard treatment for PD...
3.
Eschlboeck S, Goebel G, Eckhardt C, Fanciulli A, Raccagni C, Djamshidian A, et al.
Mov Disord Clin Pract
. 2023 Sep;
10(9):1368-1376.
PMID: 37772304
Background: Multiple system atrophy (MSA) is a devastating disease characterized by a variable combination of motor and autonomic symptoms. Previous studies identified numerous clinical factors to be associated with shorter...
4.
Monfrini E, Ciolfi A, Cavallieri F, Ferilli M, Soliveri P, Pedace L, et al.
Brain Commun
. 2022 Dec;
4(6):fcac276.
PMID: 36483457
KMT2B-related dystonia (DYT-KMT2B, also known as DYT28) is an autosomal dominant neurological disorder characterized by varying combinations of generalized dystonia, psychomotor developmental delay, mild-to-moderate intellectual disability and short stature. Disease...
5.
Pezzoli G, Cereda E, Amami P, Colosimo S, Barichella M, Sacilotto G, et al.
J Neurol
. 2022 Nov;
270(3):1564-1572.
PMID: 36436068
Objectives: There is growing evidence that Parkinson's disease and diabetes are partially related diseases; however, the association between the two, and the impact of specific treatments, are still unclear. We...
6.
Garri F, Russo F, Carrer T, Weis L, Pistonesi F, Mainardi M, et al.
J Neurol
. 2022 Aug;
269(10):5615-5616.
PMID: 35986763
No abstract available.
7.
Garri F, Russo F, Carrer T, Weis L, Pistonesi F, Mainardi M, et al.
J Neurol
. 2022 Jul;
269(10):5606-5614.
PMID: 35876875
Introduction: Levodopa/carbidopa intestinal gel (LCIG) is an effective treatment in patients with advanced Parkinson's disease (PD) with consolidated evidence of clinical efficacy. However, only few studies have assessed long-term safety,...
8.
Soliveri P, Paridi D, Del Sorbo F, Tramacere I, Girotti F
Neurol Sci
. 2022 Jan;
43(6):3695-3701.
PMID: 35067828
Background: Apathy is the commonest psychiatric manifestation in Huntington's disease (HD). We investigated negative psychiatric symptoms-as determined by the Scale for the Assessment of Negative Psychiatric Symptoms (SANS)-in early and...
9.
Barichella M, Cereda E, Iorio L, Pinelli G, Ferri V, Cassani E, et al.
Nutr Neurosci
. 2020 Nov;
25(6):1128-1136.
PMID: 33151126
Background: Parkinson's disease (PD) patients have lower levels of serum 25-hydroxyvitamin D (25(OH)D) than the general population. Previous studies have suggested a negative association between 25(OH)D and clinical features of...
10.
Cilia R, Cereda E, Akpalu A, Sarfo F, Cham M, Laryea R, et al.
Brain
. 2020 Aug;
143(8):2490-2501.
PMID: 32844196
The natural pattern of progression of Parkinson's disease is largely unknown because patients are conventionally followed on treatment. As Parkinson's disease progresses, the true magnitude of the long-duration response to...